Skip to main content
Ania Jastreboff, MD, Endocrinology, New Haven, CT

AniaMJastreboffMDPhD

Endocrinology New Haven, CT

Diabetes, Obesity, Pediatric Endocrinology

Associate Professor, Internal Medicine (Endocrinology and Metabolism) and Pediatrics (Pediatric Endocrinology), Yale University School of Medicine

Dr. Jastreboff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jastreboff's full profile

Already have an account?

  • Office

    333 Cedar St, PO Box 208020
    Yale University School Of Medicine - Endocrinology
    New Haven, CT 06510
    Phone+1 203-737-1932

Summary

  • Dr. Jastreboff is an Associate Professor at Yale University School of Medicine. She is board certified in Obesity Medicine, adult Endocrinology and Metabolism, and Pediatric Endocrinology. She is nationally/internationally recognized in the Obesity Medicine field for developing Clinical Practice Guidelines (2016) for The Comprehensive Care of Patients with Obesity (AACE/ACE), educating the next generation of Obesity Medicine physicians by teaching annually at the world renowned Harvard Blackburn Treating Obesity course and the Columbia/Cornell Obesity course, and conducting cutting-edge clinical translational obesity research. Her research includes both large, multi-center clinical outcomes trials using anti-obesity medication as well as neuroimaging studies (fMRI and PET) examining the neurobiology underlying obesity and the mechanisms of anti-obesity medications.

    Clinically, Dr. Jastreboff specializes in sophisticated use of anti-obesity medication combinations to help patients reach their weight and health goals. She mainly sees patients for obesity treatment and weight management.


    Dr. Jastreboff completed her PhD at Yale University's Investigative Medicine Program focused on translational and clinical investigation with a dissertation entitled “Neural Response to Food Cues and Stress in Individuals with Obesity".

    Dr. Jastreboff's research has been supported by NIH/NIDDK (K23, R01), American Diabetes Association (ADA), and industry funded multi-center clinical trials.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2011
  • University of Maryland
    University of MarylandResidency, Internal Medicine/Pediatrics, 2002 - 2006
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2002

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2010 - 2025
  • MD State Medical License
    MD State Medical License 2006 - 2008
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • American Board of Obesity Medicine Obesity Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Tirzepatide Linked to Significant Weight Loss, ‘Impressive’ Diabetes Prevention After 3 Years
    Tirzepatide Linked to Significant Weight Loss, ‘Impressive’ Diabetes Prevention After 3 YearsNovember 14th, 2024
  • Zepbound's Weight Loss, Cardiometabolic Benefits Hold up at 3 Years
    Zepbound's Weight Loss, Cardiometabolic Benefits Hold up at 3 YearsNovember 7th, 2024
  • What Will Happen if I Stop Taking the New Weight-Loss Drugs After Losing Weight?
    What Will Happen if I Stop Taking the New Weight-Loss Drugs After Losing Weight?August 9th, 2024
  • Join now to see all